Clinical Outcomes and Surrogate Efficacy Data for a Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients with Ischemic or Nonischemic Chronic Heart Failure

Presenter: Emerson C. Perin

REGISTER for free or LOG IN to view this content

Clinical Outcomes and Surrogate Efficacy Data for a Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients with Ischemic or Nonischemic Chronic Heart Failure

We Recommend